Get in Touch
IUCLID DOSSIER SERVICES

IUCLID Dossier Preparation & Support

Preparation, review and maintenance of IUCLID dossiers for REACH and other regulatory submissions.

IUCLID DOSSIER SUPPORT

What We Support in IUCLID Dossier Preparation

We support the preparation, review, update and quality assurance of IUCLID dossiers for REACH and other regulatory submissions.

01 IUCLID Dataset & Dossier Creation

We prepare and structure IUCLID datasets and dossiers for regulatory submissions, ensuring that the required administrative, substance and endpoint information is organised consistently and in line with the applicable submission requirements.
  • Creation of new IUCLID datasets
  • Preparation of registration and submission dossiers
  • Structuring of substance and endpoint information
  • Completion of administrative and regulatory sections
  • Coordination of required supporting information
  • Dossier generation for submission-ready output
We prepare, review and structure endpoint study records and robust study summaries in IUCLID to ensure that study information is documented clearly, consistently and with the level of detail required for regulatory assessment.
  • Preparation of endpoint study records
  • Drafting and review of robust study summaries
  • Evaluation of study reliability and adequacy
  • Documentation of study design, methods and key results
  • Consistent reporting of effect levels and endpoint conclusions
  • Quality review of existing study records
  • Identification of missing or inconsistent study information
We prepare and review substance identity, composition and administrative information in IUCLID to support a clear and consistent description of the registered substance and the legal entity responsible for the submission.
  • Substance identity and identifier documentation
  • Composition and constituent information
  • Impurity and additive information
  • Reference substance management
  • Legal entity and contact information
  • Role and submission-related administrative data
  • Review of consistency across identity and composition sections
  • Identification of missing or contradictory administrative information
We prepare and review use, exposure and classification information in IUCLID to ensure that the dossier consistently reflects how the substance is used, its hazard profile and the information required for downstream assessment.
  • Documentation of identified uses and use descriptors
  • Review of use and exposure-related information
  • Classification and labelling information
  • Harmonised and self-classification data
  • Linkage between uses, hazard information and dossier sections
  • Review of consistency with Chemical Safety Assessment information
  • Identification of missing or conflicting use and classification data
  • Coordination of relevant information with CHESAR / CSR documentation
We document and structure alternative approaches in IUCLID so that Read-Across, Weight of Evidence, QSAR and other adaptations are presented clearly, consistently and with the supporting justification required for regulatory assessment.
  • Documentation of Read-Across approaches
  • Weight of Evidence documentation
  • QSAR and computational information
  • Grouping and category approach documentation
  • Adaptation and waiving justifications
  • Supporting rationale and source information
  • Consistency between endpoint records and overall conclusions
  • Review of existing alternative approach documentation for completeness and clarity
We review IUCLID datasets and dossiers for technical completeness, consistency and submission readiness, helping identify validation issues and potential business-rule failures before submission.
  • Validation Assistant review
  • Identification of completeness and consistency issues
  • Business Rule and submission-readiness checks
  • Review of mandatory and conditionally required fields
  • Cross-checking of linked dossier sections
  • Identification of contradictory or incomplete information
  • Technical quality assurance before dossier creation
  • Support with resolving validation and submission issues
We update and maintain IUCLID datasets and dossiers when new information, regulatory changes or submission requirements make revisions necessary, and prepare the dossier for the next submission step.
  • Updating existing IUCLID datasets and dossiers
  • Incorporation of new study or hazard information
  • Updates following changes in tonnage, uses or classification
  • Revision of administrative and substance information
  • Preparation of updated dossier versions
  • Submission-readiness review before dossier creation
  • Coordination of changes across related dossier sections
  • Support with dossier generation and submission preparation
We review existing IUCLID datasets and dossiers to identify structural, technical and content-related issues and support targeted remediation where improvements are required.
  • Comprehensive review of existing IUCLID dossiers
  • Identification of incomplete, outdated or inconsistent information
  • Review of endpoint study records and summaries
  • Assessment of dossier structure and internal consistency
  • Identification of validation or submission-related weaknesses
  • Prioritisation of required corrections and updates
  • Remediation of technical and content-related deficiencies
  • Preparation of an improved and submission-ready dossier version
RELATED SERVICES

REACH Registration →

Registration strategy, data requirements, joint submission and ongoing REACH compliance support.

CHESAR / CSR →

Chemical safety assessment, exposure evaluation and CSR support.

SDS & CLP →

Classification, labelling and safety data sheet support.

Only Representative →

EU REACH representation and market access support for non-EU manufacturers.

Global Compliance →

Support for UK REACH, KKDIK, K-REACH and other international regulatory requirements.

EVOLVING IUCLID REQUIREMENTS

Support for Changing IUCLID Requirements

IUCLID formats and regulatory requirements continue to evolve. We support targeted updates where new data structures, hazard information or reporting expectations need to be reflected in existing datasets and dossiers. Select 70 more words to run Humanizer.

New Hazard Class & ED Updates

Updates related to new CLP hazard classes, endocrine disruption and other newly required hazard information.

IUCLID Format & Version Updates

Support with adapting existing IUCLID datasets and dossiers to new IUCLID versions, revised data fields, updated templates and changing dossier structures.

Training & Workshops

Support with updating IUCLID content where revised regulatory requirements, new information obligations or changing assessment expectations affect existing dossiers.

IUCLID DOSSIER FAQ

Common Questions About IUCLID Dossiers

Answers to common questions about IUCLID dossier preparation, study records, validation, updates and submission readiness.

What is the difference between an IUCLID dataset and an IUCLID dossier?

An IUCLID dataset contains the information stored for a substance, while a dossier is generated from selected dataset content for a specific regulatory submission. The dossier therefore represents a submission-specific snapshot of the underlying information.

Depending on the submission type, an IUCLID dossier may contain substance identity and composition data, endpoint study information, classification and labelling, uses, exposure information, administrative details and supporting regulatory assessments.

A robust study summary provides a structured and sufficiently detailed description of a study, including its design, methods, results and conclusions. It allows the regulatory assessor to understand the key elements of the study without relying only on a short endpoint summary.
Yes. Existing IUCLID datasets and dossiers can be reviewed for missing information, inconsistencies, outdated records, validation issues and structural weaknesses. Corrections can then be made directly in the underlying dataset before a new dossier version is generated.
The Validation Assistant helps identify technical and completeness issues within the dataset or dossier. It can highlight missing mandatory information, inconsistencies and other findings that may affect submission readiness, although successful validation does not automatically mean that the regulatory content is scientifically sufficient.
An IUCLID dossier may require updating when new study data become available, substance identity or composition changes, uses or classifications change, regulatory requirements are revised or an authority requests additional information.
Read-Across, Weight of Evidence, QSAR and other adaptations should be documented using the relevant IUCLID records together with the supporting rationale, source information and links between the affected endpoints. The documentation should allow the regulatory reasoning to be followed clearly.
Yes. Existing study reports, substance information, classifications, use information and other regulatory data can be reviewed and structured into the appropriate IUCLID records. Missing, inconsistent or unclear information can also be identified before the dossier is prepared for submission.
BEFORE YOU CONTACT US

What Helps Us Assess Your IUCLID Case

A few key details help us understand the current status of your dataset or dossier and identify the appropriate next steps.

Submission Type

REACH registration, update, inquiry or other regulatory submission

IUCLID Status

Existing dataset, dossier or IUCLID file, if available

Substance Information

CAS / EC number, composition and available substance identity information

Available Data

Study reports, endpoint records, classifications or other regulatory information

Current Objective

New dossier, update, validation issue, remediation or submission preparation

RELATED INSIGHTS

IUCLID Guidance & Regulatory Insights

Explore practical guidance on IUCLID dossier preparation, study documentation, validation, dossier updates and evolving regulatory requirements.

Need Support with an IUCLID Dossier?

Tell us about your existing data, dossier status and regulatory objective — we’ll help you identify the appropriate next steps.

DISCUSS YOUR REQUIREMENTS
CONTACT US